Stock listing

AVTX Stock Price, News, Filings & Events — Avalo Therapeutics, Inc.

Selected listing: AVTX · BOATS · USD · US

This page tracks Avalo Therapeutics, Inc.'s AVTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AVTX:BOATS. AVTX:BOATS is the stock-level entry point for investors researching Avalo Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Avalo Therapeutics, Inc. is a public company traded under the ticker AVTX in the American market. The company has a market capitalization of approximately $975.5 million. Avalo focuses on developing innovative therapies for rare diseases, aiming to improve patient outcomes through its research and development efforts.

AVTX:BOATSUSDUSUpdated September 11, 2026
Avalo Therapeutics, Inc. logo
Ticker
AVTX:BOATS
Asset type
Stock
Market cap
$864.5M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Avalo Therapeutics, Inc. AVTX:BOATS stock context

This page tracks Avalo Therapeutics, Inc.'s AVTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AVTX:BOATS. AVTX:BOATS is the stock-level entry point for investors researching Avalo Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Avalo Therapeutics, Inc. is a public company traded under the ticker AVTX in the American market. The company has a market capitalization of approximately $975.5 million. Avalo focuses on developing innovative therapies for rare diseases, aiming to improve patient outcomes through its research and development efforts.

Latest news from Avalo Therapeutics, Inc.

All Avalo Therapeutics, Inc. news →

Avalo Therapeutics, Inc. earnings calls

Research Avalo Therapeutics, Inc.

Alternate listings